JP2016138063A5 - - Google Patents

Download PDF

Info

Publication number
JP2016138063A5
JP2016138063A5 JP2015014056A JP2015014056A JP2016138063A5 JP 2016138063 A5 JP2016138063 A5 JP 2016138063A5 JP 2015014056 A JP2015014056 A JP 2015014056A JP 2015014056 A JP2015014056 A JP 2015014056A JP 2016138063 A5 JP2016138063 A5 JP 2016138063A5
Authority
JP
Japan
Prior art keywords
piperine
preventing
active ingredient
overactive bladder
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015014056A
Other languages
English (en)
Other versions
JP2016138063A (ja
JP6550234B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015014056A priority Critical patent/JP6550234B2/ja
Priority claimed from JP2015014056A external-priority patent/JP6550234B2/ja
Publication of JP2016138063A publication Critical patent/JP2016138063A/ja
Publication of JP2016138063A5 publication Critical patent/JP2016138063A5/ja
Application granted granted Critical
Publication of JP6550234B2 publication Critical patent/JP6550234B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (5)

  1. ピペリンを有効成分とする、ＴＲＰＶ４活性阻害剤。
  2. ピペリンを有効成分とする、過活動膀胱の予防又は改善剤。
  3. ピペリンを有効量適用する、非治療的ＴＲＰＶ４活性阻害方法。
  4. ピペリンを有効量適用する、非治療的過活動膀胱の予防又は改善方法。
  5. ピペリンを有効成分とする、過活動膀胱の予防又は改善用飲食品組成物。
JP2015014056A 2015-01-28 2015-01-28 Ｔｒｐｖ４活性阻害剤 Active JP6550234B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015014056A JP6550234B2 (ja) 2015-01-28 2015-01-28 Ｔｒｐｖ４活性阻害剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015014056A JP6550234B2 (ja) 2015-01-28 2015-01-28 Ｔｒｐｖ４活性阻害剤

Publications (3)

Publication Number Publication Date
JP2016138063A JP2016138063A (ja) 2016-08-04
JP2016138063A5 true JP2016138063A5 (ja) 2018-02-01
JP6550234B2 JP6550234B2 (ja) 2019-07-24

Family

ID=56559879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015014056A Active JP6550234B2 (ja) 2015-01-28 2015-01-28 Ｔｒｐｖ４活性阻害剤

Country Status (1)

Country Link
JP (1) JP6550234B2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113082032B (zh) * 2021-03-12 2022-08-12 中山大学 Trpv4激动剂的新应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170095520A1 (en) * 2014-03-21 2017-04-06 Dong Wha Pharm. Co., Ltd. A composition for preventing, treating, and improving of voiding dysfunction comprising extract of Piper longum L.

Similar Documents

Publication Publication Date Title
IL279256A (en) Sulfonimidamide compounds as inhibitors of interleukin-1 activity
ZA202001887B (en) Composition for preventing or treating tnf-related diseases, containing novel derivative as active ingredient, and method for inhibiting tnf activity by using same
HK1248235A1 (zh) 具有作為吲哚胺2，3-二加氧酶抑制劑活性的苯並咪唑和咪唑並吡啶亞氨代甲酰胺化合物
IL287268A (en) Dihydrourotate dehydrogenase inhibitors
IL284989A (en) Dihydrourotate dehydrogenase inhibitors
EP3284738A4 (en) 5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof
IL290929A (en) Transmuted cyanopyrrolidines with activity as usp30 inhibitors
IL283968A (en) Benzamides of pyrazole-amino-pyrimidine type substances and their use
IL284537A (en) Dihydrourotate dehydrogenase inhibitors
EP3626709A4 (en) INDAZOLE COMPOUND FOR USE IN INHIBITING KINASE ACTIVITY, COMPOSITION AND APPLICATION THEREOF
EP3263134A4 (en) Composition for preventing or treating valve calcification, containing dpp-4 inhibitor
EP4066835A4 (en) USE OF A COMPOSITION FOR INCREASE ANTI-CANCER EFFECT HAVING A GAMMA INHIBITOR AS THE ACTIVE INGREDIENT
EP3426244C0 (en) 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND THEIR USES
SG11202011227VA (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
GB201705457D0 (en) Aerosol compositions having improved active ingredient application
EP3421041A4 (en) COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISORDERS COMPRISING EXOPOLYSACCHARIDE PRODUCING LEUCONOSTOC MESENTEROIDES AS ACTIVE INGREDIENTS
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
EP3551613A4 (en) COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING SGK ACTIVITY AND METHOD THEREFOR
IL289586A (en) pi4kiii alpha micromolecule inhibiting preparation, method for its preparation and use
EP3327001A4 (en) NOVEL COMPOUND HAVING BLT INHIBITORY ACTIVITY AND COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING THE SAME AS ACTIVE INGREDIENT
EP2982378A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK WITH ADK PROTEIN AS AN ACTIVE SUBSTANCE
HK1259249A1 (zh) 抑制蛋白激酶活性化合物的晶型及其應用
EP3284464A4 (en) Composition for preventing and treating pancreatitis containing naphthoquinone-based compound as active ingredient
JP2016138063A5 (ja)
EP3727397C0 (en) COMPOSITION AND METHODS FOR THE TREATMENT, RELIEF OR PREVENTION OF NEUROPATHIC PAIN USING CHOLINE AFOSCERATE AS THE ACTIVE SUBSTANCE